Italy
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.57 B
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
|
2 |
USD 818.08 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
|
3 |
USD 375.16 M
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
4 |
USD 100.17 M
|
Dec. 31, 2023 | USD 9.97 | 0.35% |
|
Italy |
|
5 |
USD 54.03 M
|
Dec. 31, 2023 | USD 53.58 | -1.47% |
|
Italy |
|
6 |
USD 10.00 M
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
|
7 |
USD 6.26 M
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
8 |
USD 1.95 M
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
9 |
USD -45.90 K
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
The Healthcare company in Italy with the highest Gross Profit is Recordati Industria Chimica e Farmaceutica S.p.A. (Milan Stock Exchange: REC.MI) at USD 1.57 B.
The Healthcare company in Italy with the lowest Gross Profit is Genenta Science S.p.A. (NasdaqCM: GNTA) at USD -45.90 K.
The top 10 Healthcare companies in Italy by Gross Profit are Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., Stevanato Group S.p.A., GPI S.p.A., Pharmanutra S.p.A., Newron Pharmaceuticals S.p.A., Philogen S.p.A., Arterra Bioscience and Genenta Science S.p.A..
The bottom 10 Healthcare companies in Italy by Gross Profit are Genenta Science S.p.A., Arterra Bioscience, Philogen S.p.A., Newron Pharmaceuticals S.p.A., Pharmanutra S.p.A., GPI S.p.A., Stevanato Group S.p.A., DiaSorin S.p.A. and Recordati Industria Chimica e Farmaceutica S.p.A..